Harry Ramanantoanina, Bianca Schacherl, Attila Kovács, Michelangelo Tagliavini, Emily Marie Reynolds, Cédric Reitz, Ruwini S. K. Ekanayake, Martin Schäfer, Paul-Valentin von Massow, Jörg Göttlicher, Ralph Steininger, Kathy Dardenne, M. W. Haverkort, Martina Benešová-Schäfer, Tonya Vitova
Abstract Spectroscopic techniques are essential for accurately probing the electronic structures of coordination compounds and revealing the nature of their chemical bonding. This is particularly relevant for f -elements, where bonding interactions play crucial role, particularly in radiopharmaceutical developments. We present advanced spectroscopic analysis, including core-to-core resonant inelastic X-ray scattering (CC-RIXS) and high-energy resolution X-ray absorption near-edge structure (HR-XANES), to investigate metal-ligand interactions using lanthanum (La) as a non-radioactive homologue of actinium (Ac) applied in emerging and highly potent therapeutic radiopharmaceuticals. By analyzing the interplay between La 4 f and 5 d orbitals in various environments, we extract key information about ligand-field effects and bond covalency. Our findings demonstrate that spectroscopic features of the La L 2 -edge CC-RIXS map reflect the nephelauxetic effect, which arises from central-field 4 f orbital-specific bond covalency. The energy separation between the pre-edge and main absorption edge of the La L 2 -edge HR-XANES spectra also serves as direct probe of electron density for both 4 f and 5 d orbitals. Quantum chemical modeling, including ligand-field density-functional theory (LFDFT) and ab initio bond analysis, complements our experiments. This allows us to establish a direct correlation between spectroscopic observables and theoretical metrics for bonding properties, offering a framework to understand the coordination chemistry of f -elements. Beyond advancing fundamental chemistry, our findings will also inform future studies on Ac 3+ -radiopharmaceutical agents, where precise knowledge of bonding interactions is essential for their development.